Related Experiment Video
Updated: Aug 5, 2026
11:31
Antigens Protected Functional Red Blood Cells By The Membrane Grafting Of Compact Hyperbranched Polyglycerols
Published on: January 2, 2013
Blood Pharming of Red Cells
Romy Kronstein-Wiedemann1,2, Desiree C Brändle1,2, Stephan R Künzel1,2
1Laboratory for Experimental Transfusion Medicine, Transfusion Medicine, Med. Faculty Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
Summary
Artificial blood substitutes are being developed to address global blood shortages, especially for rare blood types. Research focuses on ex vivo red blood cell expansion, aiming for scalable and cost-effective manufacturing for clinical use.
Area of Science:
- Biotechnology
- Hematology
- Regenerative Medicine
Background:
- Blood transfusions are critical in medicine but face shortages, particularly for rare blood groups.
- The global demand for blood products necessitates the development of artificial blood substitutes.
- Research into artificial blood substitutes has been ongoing for over six decades.
Purpose of the Study:
- To review advancements in ex vivo erythropoiesis and the generation of red blood cells.
- To explore strategies for expanding erythrocyte cells and their diverse sources.
- To identify challenges and future prospects for clinical implementation of artificial blood products.
Main Methods:
- Synthesis of current research on erythropoiesis and ex vivo erythrocyte expansion.
- Analysis of impediments to clinical translation of novel blood products.
- Review of prospective applications and alternative blood substitute technologies.
Main Results:
- Ex vivo red blood cell generation has progressed to early clinical trials.
- Scalable and cost-effective manufacturing of artificial blood remains a significant challenge.
- Optimizing cell sources, progenitor lines, and bioreactor technology are crucial for progress.
Conclusions:
- Further optimization of cell sources, immortalized progenitor lines, and bioreactor technologies is essential.
- Deeper understanding of erythropoiesis and enucleation processes is required.
- Integration with regulatory frameworks may lead to standardized, universally compatible red blood cell products.
Related Concept Videos
01:22Lifecycle of Erythrocytes
Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
01:14Erythropoiesis
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
01:15Blood Transfusion
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
02:45Blood Transfusion and Agglutination
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
01:24Hemoglobin
Hemoglobin is a globular protein made up of four subunits. Two of these subunits are alpha chains, and the other two are beta chains. Each subunit contains a molecule of heme, which has an iron atom and can bind to oxygen. When an oxygen molecule binds to one heme group, it changes the shape of hemoglobin, making it easier for the other heme groups to bind oxygen as well.
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...